Cholangiolocellular carcinoma containing hepatocellular carcinoma and cholangiocellular carcinoma, extremely rare tumor of the liver : a case report

被引:18
作者
Kanamoto, Mami [1 ]
Yoshizumi, Tomoharu [1 ]
Ikegami, Toru [1 ]
Imura, Satoru [1 ]
Morine, Yuji [1 ]
Ikemoto, Tetsuya [1 ]
Sano, Nobuya [2 ]
Shimada, Mitsuo [1 ]
机构
[1] Univ Tokushima, Dept Digest & Pediat Surg, Grad Sch, Inst Hlth Biosci, Kuramoto Cho, Tokushima 7708503, Japan
[2] Univ Tokushima, Dept Pathol, Grad Sch, Inst Hlth Biosci, Tokushima, Japan
关键词
a rare tumor of the liver; cholangiocellular carcinoma; cholangiolocellular carcinoma; hepatic stem cell; hepatocellular carcinoma;
D O I
10.2152/jmi.55.161
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Cholangiolocellular carcinoma (CLC) is an extremely rare malignant liver tumor which was first defined by Steiner, et al. in 1957 (1). CLC is thought to be derived from Hering's canal because tumor glands of CLC are morphologically similar to cholangioles. Recently, Theise, et al. reported that Hering's canal might be composed of hepatic stem cells (3). In addition, CLC sometimes contains a hepatocellular carcinoma (HCC) or cholangiocellular carcinoma (CCC) component within the tumor. Those findings suggest that CLC might originate from hepatic stem cells. On the other hand, because of its low frequency, clinicopatholigical features of CLC have not been fully clarified yet. We herein report a case of a 71-year old man with CLC. Based on preoperative imagings, the hepatic tumor was diagnosed as HCC, and he underwent a partial hepatectomy. The tumor contained both a HCC and CCC-like area. In immunohistochemistry, cytokeratin (CK) 7, CK20, CAM5.2 was positive, and CK19 was negative, therefore the tumor was diagnosed as CLC. The diagnostic criteria have not been described clearly, so CLC is difficult to diagnose preoperatively. Further studies are needed to clarify the clinical and clinicopatholigical features of CLC.
引用
收藏
页码:161 / 165
页数:5
相关论文
共 15 条
[1]  
Cha I, 1999, CANCER CYTOPATHOL, V87, P25, DOI 10.1002/(SICI)1097-0142(19990225)87:1<25::AID-CNCR5>3.0.CO
[2]  
2-I
[3]   Cholangiolocellular carcinoma of the liver: CT and MR findings [J].
Fukukura, Y ;
Hamanoue, M ;
Fujiyoshi, F ;
Sasaki, M ;
Haruta, K ;
Inoue, H ;
Aiko, T ;
Nakajo, M .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2000, 24 (05) :809-812
[4]  
JAMES J, 1989, HEPATO-GASTROENTEROL, V36, P151
[5]   Intrahepatic cholangiocarcinoma arising in cirrhotic liver frequently expressed p63-positive basal/stem-cell phenotype [J].
Nomoto, K ;
Tsuneyama, K ;
Cheng, CM ;
Takahashi, H ;
Hori, R ;
Murai, Y ;
Takano, Y .
PATHOLOGY RESEARCH AND PRACTICE, 2006, 202 (02) :71-76
[6]  
Shiota K, 2001, ONCOL REP, V8, P263
[7]  
STEINER PE, 1957, ACTA UNION INT CONTR, V13, P628
[8]  
STEINER PE, 1959, CANCER, V12, P753, DOI 10.1002/1097-0142(195907/08)12:4<753::AID-CNCR2820120420>3.0.CO
[9]  
2-L
[10]  
Stroescu Cezar, 2006, J Gastrointestin Liver Dis, V15, P9